» Articles » PMID: 26647715

Bovine Parathyroid Hormone Enhances Osteoclast Bone Resorption by Modulating V-ATPase Through PTH1R

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2015 Dec 10
PMID 26647715
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The vacuolar-type H+ adenosine triphosphatase (V-ATPase) plays an important role in cellular acidification and bone resorption by osteoclasts. However, the direct effect of bovine parathyroid hormone (bPTH) on V-ATPase has not yet been elucidated. The aim of the present study was to assess the effects of bPTH on V-ATPase and osteoclasts. Osteoclasts from bone marrow (BM)-derived monocytes of C57BL/6 mice were cultured with or without bPTH. The mRNA and protein expression levels of the V-ATPase a3-subunit and d2-subunit (by RT-qPCR and western blot analysis), V-ATPase activity (using the V type ATPase Activity Assay kit) and the bone resorption function of osteoclasts (by bone resorption assay) were examined following treatment with various concentrations of bPTH (0.1, 1.0, 10 and 100 ng/ml) alone or with bPTH and its inhibitor, bafilomycin A1. Furthermore, the expression of parathyroid hormone (PTH) receptors in osteoclasts was also detected. The results revealed that the mRNA and protein expression levels of V-ATPase a3-subunit and d2-subunit increased in a dose‑dependent manner, paralleling the level of bPTH present. In addition, an increase in the concentration of bPTH was accompanied by the increased resorption capability of osteoclasts, whereas bone resorption was inhibited in the presence of bafilomycin A1. In addition, we confirmed the existence of parathyroid hormone 1 receptor (PTH1R) in osteoclasts using three different methods (RT-qPCR, western blot analysis and immunofluorescence staining). We found that bPTH enhanced the bone resorption capability of osteoclasts by modulating the expression of V-ATPase subunits, intracellular acidification and V-ATPase activity. Thus, we propose that PTH has a direct effect on osteoblasts and osteoclasts, and that this effect is mediated through PTH1R, thus contributing to bone remodeling.

Citing Articles

Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies.

Iwanowska M, Kochman M, Szatko A, Zgliczynski W, Glinicki P Int J Mol Sci. 2024; 25(21).

PMID: 39519190 PMC: 11546563. DOI: 10.3390/ijms252111639.


PTH and the Regulation of Mesenchymal Cells within the Bone Marrow Niche.

Liu H, Liu L, Rosen C Cells. 2024; 13(5.

PMID: 38474370 PMC: 10930661. DOI: 10.3390/cells13050406.


Physiological regulation of calcium and phosphorus utilization in laying hens.

Sinclair-Black M, Garcia R, Ellestad L Front Physiol. 2023; 14:1112499.

PMID: 36824471 PMC: 9942826. DOI: 10.3389/fphys.2023.1112499.


Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease.

Hou Y, Zheng C, Chiu H, Liu W, Lu K, Lu C Pharmaceuticals (Basel). 2022; 15(8).

PMID: 36015101 PMC: 9415417. DOI: 10.3390/ph15080952.


Bisphosphonate-based hydrogel mediates biomimetic negative feedback regulation of osteoclastic activity to promote bone regeneration.

Li Z, Wang H, Zhang K, Yang B, Xie X, Yang Z Bioact Mater. 2022; 13:9-22.

PMID: 35224288 PMC: 8844702. DOI: 10.1016/j.bioactmat.2021.11.004.


References
1.
Josephsen K, Praetorius J, Frische S, Gawenis L, Kwon T, Agre P . Targeted disruption of the Cl-/HCO3- exchanger Ae2 results in osteopetrosis in mice. Proc Natl Acad Sci U S A. 2009; 106(5):1638-41. PMC: 2635809. DOI: 10.1073/pnas.0811682106. View

2.
Lamothe B, Lai Y, Xie M, Schneider M, Darnay B . TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol. 2012; 33(3):582-95. PMC: 3554219. DOI: 10.1128/MCB.01225-12. View

3.
Abou-Samra A, Juppner H, Force T, Freeman M, Kong X, Schipani E . Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases.... Proc Natl Acad Sci U S A. 1992; 89(7):2732-6. PMC: 48736. DOI: 10.1073/pnas.89.7.2732. View

4.
Lee S, Lorenzo J . Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology. 1999; 140(8):3552-61. DOI: 10.1210/endo.140.8.6887. View

5.
Wang B, Liang H, Zheng F, Li X, Liu Y, Dai C . Recombinant soluble receptor activator of nuclear factor-kappaB inhibits parathyroid hormone-induced osteoclastogenesis in vitro. Sheng Li Xue Bao. 2007; 59(2):169-74. View